Since SOCS-1 methylation is only found in a subset of pancreatic adenocarcinomas, its utility as a diagnostic marker would only be as part of a panel of other aberrantly methylated genes that are specifically methylated in pancreatic cancer but not in normal pancreas. This evidence concerns the gene SOCS1 and pancreatic adenocarcinoma.